Selenium metabolism and selenoproteins function in brain and encephalopathy
- PMID: 39546178
- DOI: 10.1007/s11427-023-2621-7
Selenium metabolism and selenoproteins function in brain and encephalopathy
Abstract
Selenium (Se) is an essential trace element of the utmost importance to human health. Its deficiency induces various disorders. Se species can be absorbed by organisms and metabolized to hydrogen selenide for the biosynthesis of selenoproteins, selenonucleic acids, or selenosugars. Se in mammals mainly acts as selenoproteins to exert their biological functions. The brain ranks highest in the specific hierarchy of organs to maintain the level of Se and the expression of selenoproteins under the circumstances of Se deficiency. Dyshomeostasis of Se and dysregulation of selenoproteins result in encephalopathy such as Alzheimer's disease, Parkinson's disease, depression, amyotrophic lateral sclerosis, and multiple sclerosis. This review provides a summary and discussion of Se metabolism, selenoprotein function, and their roles in modulating brain diseases based on the most currently published literature. It focuses on how Se is utilized and transported to the brain, how selenoproteins are biosynthesized and function physiologically in the brain, and how selenoproteins are involved in neurodegenerative diseases. At the end of this review, the perspectives and problems are outlined regarding Se and selenoproteins in the regulation of encephalopathy.
Keywords: brain; encephalopathy; function; selenium; selenoprotiens.
© 2024. Science China Press.
Conflict of interest statement
Compliance and ethics. The authors declare that they have no conflict of interest.
Similar articles
-
Selenoproteins: Zoom-In to Their Metal-Binding Properties in Neurodegenerative Diseases.Int J Mol Sci. 2025 Feb 3;26(3):1305. doi: 10.3390/ijms26031305. Int J Mol Sci. 2025. PMID: 39941073 Free PMC article. Review.
-
Selenium and selenoprotein function in brain disorders.IUBMB Life. 2014 Apr;66(4):229-39. doi: 10.1002/iub.1262. Epub 2014 Mar 25. IUBMB Life. 2014. PMID: 24668686 Review.
-
Selenium homeostasis and antioxidant selenoproteins in brain: implications for disorders in the central nervous system.Arch Biochem Biophys. 2013 Aug 15;536(2):152-7. doi: 10.1016/j.abb.2013.02.021. Epub 2013 Mar 13. Arch Biochem Biophys. 2013. PMID: 23500141 Review.
-
Selenium and selenoproteins in the brain and brain diseases.J Neurochem. 2003 Jul;86(1):1-12. doi: 10.1046/j.1471-4159.2003.01854.x. J Neurochem. 2003. PMID: 12807419 Review.
-
Selenium, selenoproteins and neurodegenerative diseases.Metallomics. 2015 Aug;7(8):1213-28. doi: 10.1039/c5mt00075k. Metallomics. 2015. PMID: 25996565 Review.
Cited by
-
Selenomethionine alleviates LPS-induced PANoptosis in chicken cecum through the ROS/MAPK pathway, thereby mitigating inflammation and microbial dysbiosis.Poult Sci. 2025 Jun 4;104(9):105392. doi: 10.1016/j.psj.2025.105392. Online ahead of print. Poult Sci. 2025. PMID: 40527125 Free PMC article.
-
Nanoprobe synchrotron X-ray fluorescence microscopy reveals selenium-rich spherical structure in mouse retinal pigment epithelium.Sci Rep. 2025 Aug 1;15(1):28070. doi: 10.1038/s41598-025-11678-4. Sci Rep. 2025. PMID: 40751061 Free PMC article.
References
-
- Aachmann, F.L., Fomenko, D.E., Soragni, A., Gladyshev, V.N., and Dikiy, A. (2007). Solution structure of selenoprotein W and NMR analysis of its interaction with 14-3-3 proteins. J Biol Chem 282, 37036–37044. - DOI
-
- Aboobakar, I.F., Kinzy, T.G., Zhao, Y., Fan, B., Pasquale, L.R., Qassim, A., Kolovos, A., Schmidt, J.M., Craig, J.E., Cooke Bailey, J.N., et al. (2023). Mitochondrial TXNRD2 and ME3 genetic risk scores are associated with specific primary open-angle glaucoma phenotypes. Ophthalmology 130, 756–763. - DOI
-
- Abozaid, O.A.R., Sallam, M.W., El-Sonbaty, S., Aziza, S., Emad, B., and Ahmed, E.S.A. (2022). Resveratrol-selenium nanoparticles alleviate neuroinflammation and neurotoxicity in a rat model of Alzheimer’s disease by regulating Sirt1/miRNA-134/GSK3β expression. Biol Trace Elem Res 200, 5104–5114. - DOI
-
- Agamy, O., Ben Zeev, B., Lev, D., Marcus, B., Fine, D., Su, D., Narkis, G., Ofir, R., Hoffmann, C., Leshinsky-Silver, E., et al. (2010). Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy. Am J Hum Genet 87, 538–544. - DOI
-
- Ahmed, T., Van der Jeugd, A., Caillierez, R., Buée, L., Blum, D., D’Hooge, R., and Balschun, D. (2020). Chronic sodium selenate treatment restores deficits in cognition and synaptic plasticity in a murine model of tauopathy. Front Mol Neurosci 13, 570223. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical